Get App
Download App Scanner
Scan to Download
Advertisement
LIVE UPDATES

Sensex, Nifty Snap Four-Day Gaining Streak; Banking Stocks Drag

Sensex, Nifty  Snap Four-Day Gaining Streak; Banking Stocks Drag
The BSE signage is seen through foliage in Mumbai, India. (Photographer: Vivek Prakash/Bloomberg)
6 years ago
Catch all live updates on share prices, index moves, corporate announcements and more from the Sensex and Nifty, today.

Indian equity markets snapped a four-day gaining streak, as cues from the global markets turned adverse in the second half of trade.

Both S&P BSE Sensex and the NSE Nifty 50 index ended 1.58% lower at 34,868 and 10,305 respectively. The Sensex declined 561 points while the Nifty fell 165 points in today's trade.

Among the sectoral indices, the Nifty Bank was the top sectoral laggard; ending 3.8% or 838 points lower at 21,426. All constituents of the Nifty Bank, barring Bank of Baroda, ended with losses.

Other indices like The Nifty Metal, Nifty Pharma and Nifty Realty ended with losses of over 2% each.

The Nifty Media index snapped a seven-day winning streak to end 3% lower.

Nifty FMCG emerged as the only sectoral gainer today, ending 0.45% higher.

Broader markets fell in tandem with the benchmark indices. The Nifty Midcap and Smallcap index fell 1.4% and 1.8% respectively.

The India Volatility Index ended 2.2% higher at the mark of 30.

Market breadth ended in favour of the laggards. 1,074 stocks on the NSE ended with losses while 754 managed to post gains.

The top Nifty gainer in today's session was Asian Paints, which ended 3.8% higher while ICICI Bank and IndusInd Bank ended as the top laggards on the index, declining 7.1 and 6.67% respectively.

Shares ended 2.63% lower at Rs 87, snapping a four-day losing streak.

Shares are off the day's high, trading 4% higher at Rs 242.7, after gaining as much as 11.2%. The stock is up for the sixth straight day.

  • Top performer on the Nifty Smallcap Index
  • Gains as much as 13.2% to Rs 202.9
  • Biggest single-day gain since October 2017
  • Up for the second straight day
  • Trades at the highest level in two months
  • Up over 13% in the last two trading sessions
  • Today's volumes are 29.4 times higher than its 30-day average
  • Breaks above its 50-Day Moving Average of 173
  • 10 out of the 12 analysts tracking the stock have a buy recommendation; 0 sell calls
  • Return potential of the stock as per Bloomberg data is 87.2%

  • Worst performer on the Nifty Midcap Index
  • Falls as much as 9.2% to Rs 2,681
  • Biggest single-day fall in three months
  • Snaps two-day gaining streak
  • Today's volumes are 0.8 times higher than its 30-day average
  • Morgan Stanley downgraded the stock to equalweight and cut its price target to Rs 2,200 from Rs 2,610
  • Morgan Stanley has cut the company's FY21 and FY22 EPS estimates by 31% and 24% respectively due to lower billings
  • 10 out of the 26 analysts tracking the stock have a buy recommendation; 9 sell calls
  • The stock trades 9% above its 12-month consensus price target of Rs 2,562, implying a negative return potential

Shares fluctuated between gains and losses after the announcement. They are currently trading 0.8% lower at Rs 4,074, snapping a four-day losing streak.

  • Among top performers on the Nifty 500 index
  • Gains as much as 7.3% to Rs 432.2
  • Biggest single-day gain since September 2019
  • Trades at the highest level in over three months
  • Up for the third straight day
  • Has gained 11% in the last three trading sessions
  • Today's volumes are 2.7 times higher than its 30-day average
  • Breaks above its 100-Day Moving Average of 416.5
  • Has gained 46% from its 52-week low of Rs 293 on March 24, 2020
  • 12 out of the 20 analysts tracking the stock have a buy recommendation; 3 sell calls
  • The stock trades 2.1% higher than its 12-month consensus price target of Rs 418.3, implying a negative return potential

Shares fell as much as 5.6% to Rs 355.25 and it is among the top laggards on the Nifty 50 index.

  • Benchmark indices fall towards the day's low
  • Nifty down 0.7% at 10,399
  • Sensex down 0.6% at 35,199
  • Nifty Bank down 1.8% at 21,872
  • Nifty Midcap Index down 0.55%
  • Nifty Smallcap Index down 0.85%
  • India Volatility Index up 0.9% to 29.6
  • Nifty Pharma, Nifty Realty, Nifty Media decline over 1% each
  • Nifty FMCG off the day's high; up 0.7%
  • Nifty PSU Bank and Nifty Auto give up gains to trade flat
  • Hero MotoCorp is the top Nifty gainer; up 4.1%
  • IndusInd Bank is the top Nifty laggard; down 5%
  • 790 stocks on the NSE trade with gains while 1,004 stocks decline

Shares trade near the day's low, down 1.8% at Rs 43.65, snapping a five-day gaining streak.

Shares gained as much as 5.1% to Rs 104.35 post the announcement.

  • Trades at the highest level since January 2018
  • Gains as much as 5% to Rs 275
  • Up for the second straight day
  • Has gained in five out of the last seven trading sessions
  • Up 9% in the last seven trading sessions
  • Today's volumes are triple its 30-day average
  • Stock enters overbought territory with Relative Strength Index (RSI) at 71
  • Has more than doubled from its 52-week low of Rs 125 on March 24, 2020
  • 13 out of the 21 analysts tracking the stock have a buy recommendation; 4 sell calls
  • Stock trades 12.2% above its 12-month consensus price target of Rs 237.9, implying a negative return potential

Let's take a look at how benchmarks across Europe have opened:

  • Euro Stoxx 50 down 0.5% at 3,281
  • DAX down 0.42% at 12,467
  • CAC down 0.44% at 4,994
  • FTSE 100 down 0.6% at 6,284
  • IBEX 35 down 0.2% at 7,424

  • Among the top performers on the Nifty Midcap Index
  • Trades at a record high
  • Gains as much as 8% to Rs 1,048
  • Biggest single-day jump in over two months
  • Snaps two-day losing streak
  • Today's volumes are 2.3 times higher than its 30-day average
  • Has nearly tripled from its 52-week low of Rs 423.55 on August 23, 2019
  • 19 out of the 22 analysts tracking the stock have a buy recommendation; 1 sell call
  • The stock now trades 10.1% above its 12-month consensus price target of Rs 918.79, implying a negative return potential

Shares recovered after falling as much as 3.5% to Rs 127.1 post the announcement. The stock is currently fluctuating between gains and losses.

India's market regulator Securities and Exchange Board of India has extended the timeline to submit financial results for the quarter and year ended March 31, to July 31, Bloomberg News reports citing a SEBI statement.

The regulator had earlier set a deadline of June 30 for the same.

The revised timeline is also applicable for listed bonds and other debt issuances.

Companies, accountancy firms and industry bodies sought the extension due to continuing lockdown posing various operational challenges.

  • Benchmark indices give up gains; trade with losses
  • Sensex down 0.1% at 35,381
  • Nifty down 0.2% at 10,453
  • Nifty Bank down 1.2% at 21,994
  • Nifty Midcap Index trades little changed
  • Nifty Smallcap Index down 0.3%
  • India Volatility Index up 0.2% to 29.39
  • Nifty FMCG is the top sectoral gainer; up 1.1%
  • Nifty Media, Nifty Metal and Nifty Pharma fall between 0.5-1%
  • Asian Paints remains the top Nifty gainer; up 6.2%
  • IndusInd Bank is the top Nifty laggard; down 4%
  • 883 stocks on the NSE trade with gains while 862 decline

The pharma company received the final approval to market the Meclizine Hydrochloride tablets from the U.S. FDA. The tablets can be marketed in strengths of 12.5 mg and 25 mg. The company said in an exchange filing.

The said drug is an antihistamine used in the prevention and treatment of nausea, vomiting and dizziness caused due to motion sickness.

This drug will be manufactured in the group's manufacturing facility at SEZ, Ahmedabad.

Shares recovered from the day's low to gain as much as 1.7% to Rs 373.35. The stock is up for the second straight day.

Shares gained as much as 17% to Rs 218, post the announcement. This is the biggest single-day gain for the stock since June 2009. The stock is up for the fourth straight day and trades at the highest level in over three months.

The upstream oil explorer has halted drilling at two rigs after a staff member tested positive for Covid-19, Bloomberg News reports citing a company statement.

The company continues to operate the remaining 34 rigs on the Western Offshore with relevant safety precautions.

Western Offshore fields contribute more than 65% of the company's total oil output and 75% of the total gas production.

Shares of the company fell as much as 2.3% to Rs 83.70 per share.

  • Shares of MRPL are up 17.7% at Rs 41.55 after being locked in a 20% upper circuit. The stock is up for the third straight day.
  • Shares of State Bank of India trade 0.9% lower at Rs 190.75, snapping a five-day losing streak.
  • Shares of Coal India trade 1.25% lower at Rs 142.05.

The public sector lender's net loss narrowed in the March quarter to Rs 2,713 crore from the Rs 3,331.5 crore loss it reported in March last year.

Provisions saw a decline to Rs 3,501.7 crore, which also included exceptional harmonisation provisions of Rs 2,510 crore due to the amalgamation of Andhra Bank and Corporation Bank.

Asset quality improved with Gross NPA at 14.15% from 14.98% while net NPA fell to 5.49% from 6.85% in the previous quarter.

Shares fell as much as 4.9% to Rs 34.2, snapping a five-day gaining streak. It is also the worst performing stock on the Nifty PSU Bank index.

Shares gained as much as 20% - the biggest single-day jump since May 2014 to Rs 60.50. The stock now trades at the highest level in over three months.

The paint company reported a 6.4% decline in its net profit compared to the previous year. Revenue saw a de-growth of 8% to Rs 1,354.8 crore.

Ebitda fell 7.6% while margins remained flat at 15.4%.

The company's board of directors have approved a final dividend of Rs 0.3 per share.

Shares trade near the day's high, gaining as much as 4.5% to Rs 538.85. The stock is up for the fourth straight day.

The drugmaker has been informed by the U.S. FDA that shortage implications for Chloroquine Phosphate API has changed and that Chloroquine Phosphate drug is no longer in shortage.

The U.S. FDA had exempted the Chloroquine Phosphate and Hydroxychloroquine Sulfate APIs, manufactured at the company's Ratlam facility from an import alert.

As the Chloroquine Phosphate API is no longer in shortage, it will be excluded from the import alert.

Exception to the import alert has now been made for the API Hydroxychloroquine Sulfate, according to the exchange filing.

Shares fell as much as 2.9% to Rs 1,623, snapping a four-day losing streak.

The wheels manufacturer has bagged export orders worth $1,70,000 from the U.S. and the European Union, it said in an exchange filing.

The orders are for 20,000 wheels for the Caravan Trailer Market in the U.S. and the European Union.

This order will be executed from the company's Chennai plant from July until November.

The order will also enable ramping-up of production at the Chennai plant, the company said.

Shares gained as much as 5.2% to Rs 455, adding to Tuesday's 10.3% gain. This stock is up for the fourth straight day.

  • Benchmark indices gain for the fifth straight day
  • Nifty up 0.6% at 10,535
  • Sensex up 0.6% at 35,646
  • Nifty Bank up 0.2% at 22,302
  • Nifty Midcap Index up 1.1%
  • Nifty Smallcap Index up 1.2%
  • India Volatility Index down 0.9% to 29.1
  • Nifty Media is the top sectoral gainer; up 2.2% and is up for the eighth straight day
  • Nifty Auto, Nifty FMCG and Nifty PSU bank gain between 1.5-2%
  • Tata Motors is the top Nifty gainer; up 4.4%
  • Power Grid is the top Nifty laggard; down 1.7%
  • 1,236 stocks on the NSE trade with gains while 445 decline

Shares gained as much as 5.1% to Rs 1,769 and are up for the fifth straight day. The stock is also the top performer on the Nifty 50 index.

30.5 lakh shares of the diagnostics player exchanged hands in a single large trade on the Bombay Stock Exchange, as per Bloomberg data.

The total number of shares exchanged amount to 6% of the total equity.

The promoter group had intended to sell 23.4 lakh shares or 4.6% of the total equity in the company through a secondary placement at Rs 1,300 per share.

The floor price was a 10.5% discount to Tuesday's closing.

Post the stake sale, promoter stake will decline to 52.31% from 56.9%.

Shares fell as much as 4.7% to Rs 1,382.1 and are down for the third straight day.

The state-run lender reported a net profit of Rs 506 crore for the quarter ending March, aided by a tax write-back of Rs 2,230 crore.

The bank's Net Interest Income grew 40% as compared to the previous year while asset quality improved sequentially.

Gross NPA for the bank stood at 9.4% from 10.43% while net NPA declined to 3.13% from 4.05% in the previous quarter.

The bank's management expects the loan moratorium portfolio to come down to 35% by August. The portfolio currently stands at 65%.

Shares gained as much as 8.9% to Rs 55. The stock trades at a three-month high and is up for the sixth day in a row. This is the stock's longest winning streak since November 2019.

The stock fell as much as 6.2% to Rs 341 and is down for the fourth straight day.

Indian equity markets continued to rebound, opening higher for the fifth straight day, tracking positive cues from other Asian markets.

The S&P BSE Sensex opened 0.7% higher at 35,679 while the NSE Nifty 50 opened above the 10,500 mark at 10,529, up 0.56%. The Nifty has now gained over 3,000 points from its March low of 7,511.

Among the sectoral indices, the Nifty Bank and Nifty Auto index opened 1% higher while the PSU Bank index gained another 3%.

The Nifty Media Index opened 1.6% higher, gaining for the eighth straight day and registering its longest winning streak since December 2017.

Market breadth was in favour of the advances at the start of trade. 1,216 stocks opened with gains while 247 declined on the National Stock Exchange.

  • Total global cases cross the 9.1 million mark
  • Death toll rises to 4.74 lakh
  • Anthony Fauci, the U.S. government's top infectious-disease expert told the Congress that he was seeing a disturbing surge in cases.
  • Infections continued to surge in California, Texas and Arizona. 5,109 new cases reported in California
  • Seven new cases reported in Beijing
  • 111 deaths reported in South Africa
  • Italy reported fewest new cases since February

RBI’s Missed Opportunity In Strengthening Governance Of Housing Finance Firms

To know more about earnings reported after market hours and companies with Covid-19 updates, click here.

Catch all the live action from the global equity markets here.

Essential Business Intelligence, Continuous LIVE TV, Sharp Market Insights, Practical Personal Finance Advice and Latest Stories — On NDTV Profit.

Newsletters

Update Email
to get newsletters straight to your inbox
⚠️ Add your Email ID to receive Newsletters
Note: You will be signed up automatically after adding email

News for You

Set as Trusted Source
on Google Search